[Drugs for the treatment of Alzheimer's disease].
Nagura
Hiroshi
H
Department of Cerebrovascular Disease, Seirei Mikatahara Hospital.
D000109:Acetylcholine / Q000172:deficiency; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000209:etiology / Q000523:psychology; D000928:Antidepressive Agents / Q000627:therapeutic use; D002540:Cerebral Cortex / Q000378:metabolism; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D000077265:Donepezil; D006220:Haloperidol / Q000008:administration & dosage; D006801:Humans; D006919:Hydroxyzine / Q000008:administration & dosage; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D007189:Indans / Q000627:therapeutic use; D007273:Injections, Intramuscular; D010830:Physostigmine / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D013619:Tacrine / Q000627:therapeutic use
D000109:Acetylcholine; D000928:Antidepressive Agents; D002800:Cholinesterase Inhibitors; D000077265:Donepezil; D006220:Haloperidol; D006919:Hydroxyzine; D006993:Hypnotics and Sedatives; D007189:Indans; D010830:Physostigmine; D010880:Piperidines; D017367:Selective Serotonin Reuptake Inhibitors; D013619:Tacrine